These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16185313)

  • 1. The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus.
    Crowell MD; Mathis C; Schettler VA; Yunus T; Lacy BE
    Neurogastroenterol Motil; 2005 Oct; 17(5):738-43. PubMed ID: 16185313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation.
    James AN; Ryan JP; Crowell MD; Parkman HP
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G612-9. PubMed ID: 15107299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
    Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
    J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying.
    Raybould HE; Glatzle J; Robin C; Meyer JH; Phan T; Wong H; Sternini C
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G367-72. PubMed ID: 12409280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
    Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Tougas G; Earnest DL; Chen Y; Vanderkoy C; Rojavin M
    Aliment Pharmacol Ther; 2005 Jul; 22(1):59-65. PubMed ID: 15963081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastric solid emptying in diabetic rats and its respond to Chinese traditional medicine].
    Lan Y; Ke M; Zhang S; Li F; Liang X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Oct; 22(5):411-5. PubMed ID: 12903417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT4 receptor agonist.
    Campbell-Dittmeyer K; Hicks GA; Earnest DL; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2009 Nov; 21(11):1197-e108. PubMed ID: 19210632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M; Fruehauf H; Stutz B; Tougas G; Salter J; Fried M
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1399-407. PubMed ID: 17892526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension.
    Greenwood-Van Meerveld B; Venkova K; Hicks G; Dennis E; Crowell MD
    Neurogastroenterol Motil; 2006 Jan; 18(1):76-86. PubMed ID: 16371086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric emptying by triterpene saponin, momordin Ic, in mice: roles of blood glucose, capsaicin-sensitive sensory nerves, and central nervous system.
    Matsuda H; Li Y; Yamahara J; Yoshikawa M
    J Pharmacol Exp Ther; 1999 May; 289(2):729-34. PubMed ID: 10215646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia.
    Tack J; Janssen P; Bisschops R; Vos R; Phillips T; Tougas G
    Neurogastroenterol Motil; 2011 Feb; 23(2):e32-9. PubMed ID: 20979591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronized gastric electrical stimulation improves delayed gastric emptying in nonobese mice with diabetic gastroparesis.
    Song GQ; Chen JD
    J Appl Physiol (1985); 2007 Nov; 103(5):1560-4. PubMed ID: 17717123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegaserod inhibits the serotonin transporter SERT.
    Ismair MG; Kullak-Ublick GA; Blakely RD; Fried M; Vavricka SR
    Digestion; 2007; 75(2-3):90-5. PubMed ID: 17510552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of tegaserod in critically ill patients with impaired gastric motility.
    Banh HL; MacLean C; Topp T; Hall R
    Clin Pharmacol Ther; 2005 Jun; 77(6):583-6. PubMed ID: 15961989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
    Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
    Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study.
    Kwiatek MA; Fox MR; Steingoetter A; Menne D; Pal A; Fruehauf H; Kaufman E; Forras-Kaufman Z; Brasseur JG; Goetze O; Hebbard GS; Boesiger P; Thumshirn M; Fried M; Schwizer W
    Neurogastroenterol Motil; 2009 Sep; 21(9):928-e71. PubMed ID: 19413683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
    Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.